EFSA Schedules Consultation on Gut Health and Immune Function Health Claims
As part of the European Food Safety Authority's (EFSA; Parma, Italy) ongoing series of public consultations on health claims guidance, the agency has announced that it will hold a meeting on scientific requirements for gut health and immune function health claims on December 2, 2010, in Amsterdam.
As part of the European Food Safety Authority's (EFSA; Parma, Italy) ongoing series of public consultations on health claims guidance, the agency has announced that it will hold a meeting on scientific requirements for gut health and immune function health claims on December 2, 2010, in Amsterdam.
The meeting will come after a public consultation on a gut health draft guidance, which will be presented to the public in October. This draft guidance will later be revised, taking into consideration the December meeting's discussions and those comments submitted to EFSA up to that point.
Gut health experts and food industry scientists will be allowed to participate in the meeting. Open registration begins in September and is limited to around 100, says EFSA.
Other future health claims consultations planned by EFSA include blood glucose control and weight management, energy, and satiety (February 2011); cardiovascular health and protection against oxidative damage (May 2011); cognitive function and bone, joint, and oral health (September 2011); and physical performance (February 2012).
For more information, visit EFSA here.
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
